Chimerix holds the potential to have the first approval of dordaviprone for treating recurrent H3 K27M mutant high-grade ...
Telix is in a strong financial position with net cash of AUD 140 million as of December 2024. We forecast free cash flow averaging 87% of net income over the next 10 years, and in the absence of major ...
Imaging technology developed and refined at the University of Waterloo promises better detection and treatment of breast ...
Firefighters face a greater risk of developing and dying from cancer than from dying while on duty. That harsh reality led to the launch of ...
12h
AZoLifeSciences on MSNImmunotherapy Breakthrough Targets Jumbled Proteins in GliomaImmune therapy has transformed how cancer is treated, but many tumors continue to evade these treatments, thanks to their resemblance to healthy tissue.
The intestinal epithelium is a highly dynamic barrier that regulates digestion, absorption, immune responses, and ...
Groundbreaking findings from the landmark CLEAR (Clinical trial Comparing Lenvatinib with Ecerolimus or Pembrolizumab in ...
One in 60 people in the U.S. lives with a traumatic brain injury related disability. Here, we discuss the long-term effects ...
Researchers at Yale University in a small, yet to be published study found that Covid vaccines were linked to a rare ...
Cleveland Clinic researchers are three years into a longitudinal brain study, in which volunteers are undergoing periodic medical imaging, cognitive assessments and neuropsychological exams to help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results